unknown
Stage
About
IndiTreat is a family of CE IVD-marked functional drug sensitivity tests developed and run by 2cureX that use patient-derived organoids to predict metastatic colorectal cancer (mCRC) patients' responses and resistance to chemotherapy regimens.
Explore IndiTreat (2cureX)'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.